Exalenz Bioscience Ltd.

www.exalenz.com

Formerly BreathID

High-Tech Company

Acquired by Meridian Bioscience

TAGS

Diagnostics, Medical Devices

General Data

Sector	Life Sciences
Sub-Sector	Biotechnology

TECHNOLOGY

The BreathID® system is an advanced technology platform used to assess a range of liver and gastrointestinal disorders via molecular analysis of the patient’s exhaled breath. The system is the only breath-testing technology with the ability...(Unlock More)...

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

PIPE

Jul. 24, 2016

Initial Revenues

$6.15m

$17m

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated: Feb 20, 2020